D

Drew M. Pardoll

Bloomberg (United States)

ORCID: 0000-0001-6215-1013

Publishes on Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune Cell Function and Interaction. 895 papers and 167.9k citations.

PubIndex Score98Top 2%How it's scored

895Publications

167.9kTotal Citations

First publication: 1980First senior author: 1976

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Immune Cell Function and Interaction CAR-T cell therapy research T-cell and B-cell Immunology

Top publicationsby citations

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian, Mario Sznol, F. Stephen Hodi et al.|New England Journal of Medicine|2012

Cited by 12.6k

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Dung T. Le, Luis A. Díaz, Jennifer N. Uram et al.|New England Journal of Medicine|2015

Cited by 9.4k

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Julie R. Brahmer, Jon M. Wigginton, Scott S. Tykodi et al.|New England Journal of Medicine|2012

Cited by 8k

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Dung T. Le, Luis A. Díaz, Jennifer N. Durham et al.|Science|2017

Cited by 6.6k

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

Suzanne L. Topalian, F. Stephen Hodi, Mario Sznol et al.|Journal of Clinical Oncology|2014

Cited by 2.2k